<DOC>
	<DOCNO>NCT00194129</DOCNO>
	<brief_summary>This study determine efficacy safety combination therapy divalproex lithium treat mania people rapid cycle bipolar disorder substance abuse disorder .</brief_summary>
	<brief_title>Lithium Divalproex Treatment Comorbid Rapid Cycling Bipolar Disorder Substance Abuse Disorder</brief_title>
	<detailed_description>Longitudinal Evaluation Efficacy Safety Divalproex Lithium Dual Diagnosis Bipolar Rapid Cycling : This study recruit male female age 18 old currently meet diagnostic criterion rapid cycle bipolar disorder ( type I II ) meet criterion substance abuse dependence cocaine , marijuana and/or alcohol within past six month . Patients initially stabilize dual therapy lithium depakote randomly assign double-blind treatment either lithium monotherapy continue dual therapy . Patients remain study six month experience relapse . Patients study require bring friend family member study visit well attend chemical dependency service . This study sponsor NIMH . Subjects receive study-related care cost .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>To include study , patient require either acutely hypomanic manic define Diagnostic Statistical Manual IV ( DSMIV ) meet criterion current substance abuse and/or dependence disorder within last six month . Must 4 episode immediate 12 month prior study entry . Males females 16 65 year age . A score 60 less Global Assessment Scale . Have medical illness precluding use lithium divalproex . Patients intolerable side effect lithium level 0.8 meq/L divalproex level 50 ug/ml . Patients completely nonresponsive lithium past exclude , whereas patient partial response lithium permit study . Patients prior history seizure disorder , cerebral vascular disease , structural brain damage trauma , clinically significant focal neurological abnormality , EEG abnormalities frank paroxysmal activity previous CT/MRI scan brain gross structural abnormality . Patients require anticoagulant drug therapy . Patients uncontrolled gastrointestinal , renal , hepatic , endocrine , cardiovascular , pulmonary , immunological hematological disease . Patients alcoholrelated liver disease reflect diffuse elevation liver function test exceed upper limit normal range 50 % exclude . Patients pregnant plan become pregnant study . Patients receive haloperidol decanoate fluphenazine decanoate within last 10 week . Patients central nervous system ( CNS ) neoplasm , uncontrolled metabolic , demyelinate progressive disorder ; active CNS infection ; progressive neurological disorder . Patients take exogenous steroid . Patients meet criterion substance abuse dependence .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>